Skip to main content
Premium Trial:

Request an Annual Quote

Thomas Baer, Charles Wang


Thomas Baer, the founder and CEO of Mountain View, Calif.-based Arcturus, has been elected as a fellow of the American Association for the Advancement of Science. Baer, who holds more than 45 patents, was elected for his “inventive developments in advanced electro-optical technology and their effective commercial dissemination.”

Previous to joining Arcturus, which develops systems for linear amplification of DNA and other microgenomics systems, Baer served as vice president and director of research at Biometric Imaging, now a subsidiary of Becton, Dickinson. He also served as vice president and director of research for Spectra-Physics, and founder of Spectra-Physics Laser Diode Systems.

People wanted: A microarray core facility for a Los Angeles, Calif., medical research institute, is looking for a research fellow to conduct gene expression profiling and microarray data mining for cancer studies. The position requires a PhD or the equivalent in molecular biology or a related field, as well as experience in molecular biology methods such as cDNA synthesis, Northern blotting, PCR, RT-PCR, and RNA isolation. Helpful experience also includes previous work with DNA microarrays and bioinformatics, as well as experience with in vitro gene expression and TaqMan. The applicant must be a US citizen or a legal resident alien. For more information e-mail Charles Wang at [email protected]

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.